Ep125: Barry Greene on a New Drug for Depression
Barry Greene, CEO of Cambridge, Mass.-based Sage …
The Long Run with Luke Timmerman · Timmerman Report
December 19, 20221h 4m
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.